Cyclobenzaprine: positive opinion from EMA in Rapid Scientific Advice procedure as a possible anti-Covid-19 therapy
M-Squared Consulting, a consultancy company for life sciences companies in the management of pharmaceutical contracts, has received a first positive signal from EMA’s Pandemic Task Force in the Rapid Scientific Advice1 procedure for potential treatments for Covid-19 in the repositioning project for cyclobenzaprine, a drug for the treatment of acute musculoskeletal conditions. Cyclobenzaprine, based on preclinical scientific evidence, has…
